Efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in nasopharyngeal carcinoma in vitro and in vivo-Reference-Cited by-同舟云学术

Efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in nasopharyngeal carcinoma in vitro and in vivo

Published:2018-05-03 Issue:1 Volume:38 Page:15
ISSN:2523-3548
Container-title:Cancer Communications
language:en
Short-container-title:Cancer Communications

Author:

Huang Yan¹²,Tian Ying¹³,Zhao Yuanyuan¹²,Xue Cong¹²,Zhan Jianhua¹³,Liu Lin⁴,He Xiaobo⁵,Zhang Li¹²

Affiliation:

1. State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy; Sun Yat-sen University Cancer Center; Guangzhou 510060 Guangdong P. R. China

2. Department of Medical Oncology; Sun Yat-sen University Cancer Center; Guangzhou 510060 Guangdong P. R. China

3. Department of Experimental Research; Sun Yat-Sen University Cancer Center; Guangzhou 510060 Guangdong P. R. China

4. Department of Medical Oncology, The Fifth Affiliated Hospital; Sun Yat-Sen University; Zhuhai 519000 Guangdong P. R. China

5. Department of Radiation Oncology, The Fifth Affiliated Hospital; Sun Yat-Sen University; Zhuhai 519000 Guangdong P. R. China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s40880-018-0285-0.pdf

Reference27 articles.

1. Exploiting tumour hypoxia in cancer treatment;Brown;Nat Rev Cancer,2004

2. Targeting hypoxia in cancer therapy;Wilson;Nat Rev Cancer,2011

3. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects;Hockel;J Natl Cancer Inst.,2001

4. Bioreductive prodrugs as cancer therapeutics: targeting tumor hypoxia;Guise;Chin J Cancer,2014

5. The enigmatic epidemiology of nasopharyngeal carcinoma;Chang;Cancer Epidemiol Prev Biomark,2006

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prodrug-conjugated tumor-seeking commensals for targeted cancer therapy;Nature Communications;2024-05-21

2. Influence of the Hypoxia-Activated Prodrug Evofosfamide (TH-302) on Glycolytic Metabolism of Canine Glioma: A Potential Improvement in Cancer Metabolism;Cancers;2023-11-22

3. Metabolic reprogramming in nasopharyngeal carcinoma: Mechanisms and therapeutic opportunities;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-11

4. Research Progress of Epigenetic Modification on the Regulation of Transporters Under Hypoxia;Current Drug Metabolism;2023-02

5. Manipulate tumor hypoxia for improved photodynamic therapy using nanomaterials;European Journal of Medicinal Chemistry;2023-02